Indaptus Therapeutics Inc. (INDP) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Indaptus Therapeutics Inc...

    NASDAQ: INDP · Real-Time Price · USD
    3.49
    0.21 (6.40%)
    At close: Sep 26, 2025, 3:59 PM
    3.30
    -5.46%
    After-hours: Sep 26, 2025, 07:56 PM EDT

    Indaptus Therapeutics Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Revenue
    		 n/a n/a n/a n/a
    Cost of Revenue
    		 735.00 1.28K 1.78K 1.4K
    Gross Profit
    		 -735 -1.28K -1.78K -1.4K
    Operating Income
    		 -15.37M -16.38M -14.91M -7.73M
    Interest Income
    		 n/a n/a 588.11K 17.72K
    Pretax Income
    		 -15.02M -15.42M -14.32M -7.71M
    Net Income
    		 -15.02M -15.42M -14.32M -7.69M
    Selling & General & Admin
    		 8.11M 8.76M 8.59M 5.21M
    Research & Development
    		 7.25M 7.62M 6.32M 2.52M
    Other Expenses
    		 n/a n/a n/a n/a
    Operating Expenses
    		 15.37M 16.38M 14.91M 7.73M
    Interest Expense
    		 n/a n/a 588.11K n/a
    Selling & Marketing Expenses
    		 n/a 100.74K n/a n/a
    Cost & Expenses
    		 -15.37M 16.38M 14.91M 7.73M
    Income Tax Expense
    		 n/a n/a -588.11K -17.72K
    Shares Outstanding (Basic)
    		 9.36M 8.4M 8.26M 4.09M
    Shares Outstanding (Diluted)
    		 9.36M 8.4M 8.26M 4.09M
    EPS (Basic)
    		 -1.61 -1.84 -1.73 -1.89
    EPS (Diluted)
    		 -1.61 -1.84 -1.73 -1.89
    EBITDA
    		 -15.02M -16.38M -14.91M -7.73M
    EBIT
    		 -15.02M -16.38M -14.91M -7.73M
    Depreciation & Amortization
    		 735.00 1.28K 1.78K 1.4K

    Add to Watchlist